Development of a staging system for hepatoid adenocarcinoma of the stomach based on multicenter data: a retrospective cohort study
Authors:
- Ying-Qi HuangYHYing-Qi Huang
- Ze-Ning HuangZHZe-Ning Huang
- Qing-Qi HongQHQing-Qi Hong
- Peng ZhangPZPeng Zhang
- Zi-Zhen ZhangZZZi-Zhen Zhang
- Liang HeLHLiang He
- Liang ShangLSLiang Shang
- Lin-Jun WangLWLin-Jun Wang
- Ya-Feng SunYSYa-Feng Sun
- Zhi-Xiong LiZLZhi-Xiong Li
- Jun-Jie LiuJLJun-Jie Liu
- Fang-Hui DingFDFang-Hui Ding
Open Access
- 24 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (1) , 718-727
Abstract
Background: Hepatoid adenocarcinoma of the stomach (HAS) is a rare subtype of gastric cancer (GC) with a poor prognosis. Furthermore, the current pathological staging system for HAS does not distinguish it from that for common gastric cancer (CGC). Methods: The clinicopathological data of 251 patients with primary HAS who underwent radical surgery at 14 centers in China from April 2004 to December 2019 and 5082 patients with primary CGC who underwent radical surgery at two centers during the same period were retrospectively analyzed. A modified staging system was established based on the differences in survival. Results: After 1:4 propensity score matching (PSM), 228 patients with HAS and 828 patients with CGC were analyzed. Kaplan–Meier (K–M) analysis showed patients with HAS had a poorer prognosis compared with CGC. Multivariate analysis identified pN stage, CEA level, and perineural invasion (PNI) as independent prognostic factors in patients with HAS. A modified pT (mpT) staging was derived using recursive partitioning analysis (RPA) incorporating PNI and pT staging. The modified pathological staging system (mpTNM) integrated the mpT and the eighth American Joint Committee on Cancer (AJCC) pN definitions. Multivariate analysis showed that the mpTNM stage outperformed other pathological variables as independent predictors of OS and RFS in patients with HAS. The mpTNM staging system exhibited significantly higher predictive accuracy for 3-year OS in patients with HAS (0.707, 95% CI: 0.650–0.763) compared to that of the eighth AJCC staging system (0.667, 95% CI: 0.610–0.723, P P <0.05). The time-dependent ROC curve showed that the mpTNM staging system consistently outperformed the eighth AJCC staging system with increasing observation time. Conclusion: The mpTNM staging system exhibited superior postoperative prognostic accuracy for patients with HAS compared to the eighth AJCC staging system.Keywords
This publication has 34 references indexed in Scilit:
- Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the StomachJAMA Network Open, 2021
- Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPEGastric Cancer, 2021
- What you need to know: updates in penile cancer stagingWorld Journal of Urology, 2020
- Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular featuresGastric Cancer, 2019
- Perineural invasion in cancerCancer, 2009
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Perineural invasion as a predictor of recurrence of gastric cancerCancer, 1994
- Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysisCancer, 1993
- Neural cell adhesion molecule (NCAM) and perineural invasion in bile duct cancerJournal of Surgical Oncology, 1993
- Hepatoid adenocarcinomas of the stomach: An analysis of seven casesCancer, 1986